Literature DB >> 28385287

Mice with infectious colitis exhibit linear growth failure and subsequent catch-up growth related to systemic inflammation and IGF-1.

Mark D DeBoer1, Vidhya Vijayakumar2, Meiqing Gong2, John L Fowlkes3, Rachel M Smith2, Fernando Ruiz-Perez2, James P Nataro2.   

Abstract

In developing communities, intestinal infection is associated with poor weight gain and linear-growth failure. Prior translational animal models have focused on weight gain investigations into key contributors to linear growth failure have been lacking. We hypothesized that murine intestinal infection with Citrobacter rodentium would induce linear-growth failure associated with systemic inflammation and suppressed serum levels of insulin-like growth factor-1 (IGF-1). We evaluated 4 groups of mice infected or sham-infected on day-of-life 28: uninfected-controls, wild-type C rodentium-infected, partially-attenuated C rodentium-infected (with deletion of 3 serine protease genes involved in colonization), and pair-fed (given the amount of daily food consumed by the wild-type C rodentium group). Relative to the uninfected group, mice infected with wild-type C rodentium exhibited temporal associations of lower food intake, weight loss, linear-growth failure, higher IL-6 and TNF-α and lower IGF-1. However, relative to the pair-fed group, the C rodentium-infected group only differed significantly by linear growth and systemic inflammatory cytokines. Between post-infection days 15-20, the infected group exhibited resolution of systemic inflammation. Between days 16-20, both wild-type C rodentium and pair-fed groups exhibited rapid linear-growth velocities exceeding the uninfected and mutant C rodentium groups; during this time levels of IGF-1 increased to match the uninfected group. We submit this as a model providing important opportunities to study mechanisms of catch-up growth related to intestinal inflammation. We conclude that in addition to known effects of weight loss, infection with C rodentium induces linear-growth failure potentially related to systemic inflammation and low levels of IGF-1, with catch-up of linear growth following resolution of inflammation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Citrobacter rodentium; Diarrhea; Growth failure; Inflammation; Insulin-like growth factor-1

Mesh:

Substances:

Year:  2017        PMID: 28385287      PMCID: PMC5394935          DOI: 10.1016/j.nutres.2017.02.005

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  37 in total

Review 1.  Insulin-like growth factor-I resistance.

Authors:  S Jain; D W Golde; R Bailey; M E Geffner
Journal:  Endocr Rev       Date:  1998-10       Impact factor: 19.871

Review 2.  Catch-up growth.

Authors:  B Boersma; J M Wit
Journal:  Endocr Rev       Date:  1997-10       Impact factor: 19.871

3.  Patterns of catch-up growth.

Authors:  Caroline C de Wit; Theo C J Sas; Jan M Wit; Wayne S Cutfield
Journal:  J Pediatr       Date:  2012-11-13       Impact factor: 4.406

Review 4.  Nutritional regulation of the insulin-like growth factors.

Authors:  J P Thissen; J M Ketelslegers; L E Underwood
Journal:  Endocr Rev       Date:  1994-02       Impact factor: 19.871

Review 5.  Growth and the Growth Hormone-Insulin Like Growth Factor 1 Axis in Children With Chronic Inflammation: Current Evidence, Gaps in Knowledge, and Future Directions.

Authors:  S C Wong; R Dobie; M A Altowati; G A Werther; C Farquharson; S F Ahmed
Journal:  Endocr Rev       Date:  2015-12-31       Impact factor: 19.871

6.  Role of class 1 serine protease autotransporter in the pathogenesis of Citrobacter rodentium colitis.

Authors:  Vidhya Vijayakumar; Araceli Santiago; Rachel Smith; Mark Smith; Roy M Robins-Browne; James P Nataro; Fernando Ruiz-Perez
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

7.  Growth failure occurs through a decrease in insulin-like growth factor 1 which is independent of undernutrition in a rat model of colitis.

Authors:  A B Ballinger; O Azooz; T El-Haj; S Poole; M J Farthing
Journal:  Gut       Date:  2000-05       Impact factor: 23.059

8.  Modulation of inflammation-induced changes in insulin-like growth factor (IGF)-I and IGF binding protein-1 by anti-TNF antibody.

Authors:  J Fan; Y H Li; G J Bagby; C H Lang
Journal:  Shock       Date:  1995-07       Impact factor: 3.454

Review 9.  Bacterial serine proteases secreted by the autotransporter pathway: classification, specificity, and role in virulence.

Authors:  Fernando Ruiz-Perez; James P Nataro
Journal:  Cell Mol Life Sci       Date:  2013-05-21       Impact factor: 9.261

10.  Interleukin-6 inhibits hepatic growth hormone signaling via upregulation of Cis and Socs-3.

Authors:  Lee A Denson; Matthew A Held; Ram K Menon; Stuart J Frank; Albert F Parlow; Dodie L Arnold
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01-02       Impact factor: 4.052

View more
  3 in total

1.  Increases in IGF-1 After Anti-TNF-α Therapy Are Associated With Bone and Muscle Accrual in Pediatric Crohn Disease.

Authors:  Mark D DeBoer; Arthur M Lee; Kirabo Herbert; Jin Long; Meena Thayu; Lindsay M Griffin; Robert N Baldassano; Lee A Denson; Babette S Zemel; Michelle R Denburg; Rita Herskovitz; Mary B Leonard
Journal:  J Clin Endocrinol Metab       Date:  2018-03-01       Impact factor: 5.958

2.  Systemic Inflammation in the First 2 Weeks after Birth as a Determinant of Physical Growth Outcomes in Hospitalized Infants with Extremely Low Gestational Age.

Authors:  Mandy B Belfort; Sara E Ramel; Camilia R Martin; Raina Fichorova; Karl C K Kuban; Timothy Heeren; Rebecca C Fry; T Michael O'Shea
Journal:  J Pediatr       Date:  2021-09-08       Impact factor: 4.406

3.  Effect of scheduled antimicrobial and nicotinamide treatment on linear growth in children in rural Tanzania: A factorial randomized, double-blind, placebo-controlled trial.

Authors:  Mark D DeBoer; James A Platts-Mills; Sarah E Elwood; Rebecca J Scharf; Joann M McDermid; Anne W Wanjuhi; Samwel Jatosh; Siphael Katengu; Tarina C Parpia; Elizabeth T Rogawski McQuade; Jean Gratz; Erling Svensen; Jonathan R Swann; Jeffrey R Donowitz; Paschal Mdoe; Sokoine Kivuyo; Eric R Houpt; Estomih Mduma
Journal:  PLoS Med       Date:  2021-09-28       Impact factor: 11.069

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.